These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 36898877)

  • 1. Successful Treatment of Fibro-Adipose Vascular Anomaly with Sirolimus.
    Wang Z; Yan H; Ding Y; Gong Y; Ma Y; Yao W; Li K
    J Pediatr Surg; 2023 Jul; 58(7):1337-1341. PubMed ID: 36898877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibro-adipose vascular anomaly (FAVA) - diagnosis, staging and management.
    Wang H; Xie C; Lin W; Wang P; Yang W; Guo Z
    Orphanet J Rare Dis; 2023 Nov; 18(1):347. PubMed ID: 37936141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibro-adipose vascular anomaly: clinical-radiologic-pathologic features of a newly delineated disorder of the extremity.
    Alomari AI; Spencer SA; Arnold RW; Chaudry G; Kasser JR; Burrows PE; Govender P; Padua HM; Dillon B; Upton J; Taghinia AH; Fishman SJ; Mulliken JB; Fevurly RD; Greene AK; Landrigan-Ossar M; Paltiel HJ; Trenor CC; Kozakewich HP
    J Pediatr Orthop; 2014 Jan; 34(1):109-17. PubMed ID: 24322574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibro-adipose vascular anomaly (FAVA): three case reports with an emphasis on the mammalian target of rapamycin (mTOR) pathway.
    Hori Y; Hirose K; Aramaki-Hattori N; Suzuki S; Nakayama R; Inoue M; Matsui T; Kohara M; Toyosawa S; Morii E
    Diagn Pathol; 2020 Jul; 15(1):98. PubMed ID: 32711543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibroadipose vascular anomaly treated with sirolimus: Successful outcome in two patients.
    Erickson J; McAuliffe W; Blennerhassett L; Halbert A
    Pediatr Dermatol; 2017 Nov; 34(6):e317-e320. PubMed ID: 29144050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibro-Adipose Vascular Anomaly: Characteristic Imaging Features on Sonography and Magnetic Resonance Imaging.
    Hu W; Gong Y; Ma J; Wu G
    Vasc Endovascular Surg; 2023 Feb; 57(2):106-113. PubMed ID: 36168791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lower Extremity Fibro-Adipose Vascular Anomaly (FAVA): A New Case of a Newly Delineated Disorder.
    Fernandez-Pineda I; Marcilla D; Downey-Carmona FJ; Roldan S; Ortega-Laureano L; Bernabeu-Wittel J
    Ann Vasc Dis; 2014; 7(3):316-9. PubMed ID: 25298836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cryoablation in fibro-adipose vascular anomaly (FAVA): a minimally invasive treatment option.
    Shaikh R; Alomari AI; Kerr CL; Miller P; Spencer SA
    Pediatr Radiol; 2016 Jul; 46(8):1179-86. PubMed ID: 26902298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical Management of Fibroadipose Vascular Anomaly of the Lower Extremities.
    Wang KK; Glenn RL; Adams DM; Alomari AI; Al-Ibraheemi A; Anderson ME; Chaudry G; Fishman SJ; Greene AK; Shaikh R; Trenor CC; Kozakewich HP; Spencer SA
    J Pediatr Orthop; 2020 Mar; 40(3):e227-e236. PubMed ID: 31181028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and imaging features in fibro-adipose vascular anomaly (FAVA).
    Amarneh M; Shaikh R
    Pediatr Radiol; 2020 Mar; 50(3):380-387. PubMed ID: 31834427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower Extremity Fibro-Adipose Vascular Anomaly-Case Report.
    Ferreira J; López Gutiérrez JC; Carneiro A; Sousa PP; Braga S; Simões JC; Carrilho C; Mesquita A
    Ann Vasc Surg; 2020 Jul; 66():671.e15-671.e18. PubMed ID: 32018020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MRI-based radiomics in distinguishing Kaposiform hemangioendothelioma (KHE) and fibro-adipose vascular anomaly (FAVA) in extremities: A preliminary retrospective study.
    Ding Y; Wang Z; Xu P; Ma Y; Yao W; Li K; Gong Y
    J Pediatr Surg; 2022 Jul; 57(7):1228-1234. PubMed ID: 35418319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PIK3CA mutation correlates with mTOR pathway expression but not clinical and pathological features in Fibfibroipose vascular anomaly (FAVA).
    Hori Y; Hirose K; Ozeki M; Hata K; Motooka D; Tahara S; Matsui T; Kohara M; Higashihara H; Ono Y; Tanaka K; Toyosawa S; Morii E
    Diagn Pathol; 2022 Jan; 17(1):19. PubMed ID: 35094709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endoscopic Resection for Vascular Anomalies in Children: A New Standard.
    Wang H; Xie C; Lin W; Zhou J; Yang W; Guo Z
    Ann Surg; 2023 Oct; 278(4):e870-e875. PubMed ID: 36825502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibro-Adipose Vascular Anomaly (FAVA): Not Another Vascular Anagram.
    Barwad A; Narwal A; Dutta R; Behera R; Kumar VS; Rastogi S; Mridha AR
    Int J Surg Pathol; 2023 Jul; ():10668969231188419. PubMed ID: 37461272
    [No Abstract]   [Full Text] [Related]  

  • 16. MRI for Response Assessment of Extensive Lymphatic Malformations in Children Treated With Sirolimus.
    Durand R; Reid JR; Belasco JB; Shellikeri S; Calle-Toro JS; Cahill AM; Srinivasan A
    AJR Am J Roentgenol; 2021 Sep; 217(3):741-752. PubMed ID: 33405944
    [No Abstract]   [Full Text] [Related]  

  • 17. [Our experience with sirolimus for the treatment of complicated vascular anomalies].
    Giménez-Aleixandre C; Méndez-Aguirre NA; Martínez-Menchón T; Girón Vallejo Ó; Fernández-Ibieta M; Ferri-Ñíguez B; Villamil V; Sánchez-Sánchez Á; Montoya-Rangel CA; Hernández-Bermejo JP
    Cir Pediatr; 2019 Jan; 32(1):28-33. PubMed ID: 30714698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus in the Treatment of Vascular Anomalies.
    Triana P; Dore M; Cerezo VN; Cervantes M; Sánchez AV; Ferrero MM; González MD; Lopez-Gutierrez JC
    Eur J Pediatr Surg; 2017 Feb; 27(1):86-90. PubMed ID: 27723921
    [No Abstract]   [Full Text] [Related]  

  • 19. The Use of Sirolimus for Treatment of Orbital Lymphatic Malformations: A Systematic Review.
    Shoji MK; Shishido S; Freitag SK
    Ophthalmic Plast Reconstr Surg; 2020; 36(3):215-221. PubMed ID: 31990892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress about the fibro-adipose vascular anomaly: A review.
    Sun YR; Zou ML; Yuan SM
    Medicine (Baltimore); 2024 Feb; 103(7):e37225. PubMed ID: 38363925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.